Zobrazeno 1 - 10
of 5 507
pro vyhledávání: '"Acute myeloid leukaemia"'
Autor:
Shweta Agarwal, Shruti Sharma, Monal Trisal, Zeeba S Jairajpuri, Sujala Kapur, Sumita Saluja, Purnima Paliwal
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 18, Iss 11, Pp 01-06 (2024)
Introduction: The bone marrow examination is an essential investigation in the diagnosis and management of many haematological disorders. The integration of all investigations, including peripheral blood analysis, bone marrow aspirate, and trephine b
Externí odkaz:
https://doaj.org/article/ab147597715043dfa8a1f5326789bd0f
Autor:
Carla Ijurko, Marta Romo-González, Rodrigo Prieto-Bermejo, María Díez-Campelo, María-Belén Vidriales, Sandra Muntión, Fermín Sánchez-Guijo, Jesús Sánchez-Yagüe, Ángel Hernández-Hernández
Publikováno v:
Biomarker Research, Vol 12, Iss 1, Pp 1-6 (2024)
Abstract Acute myeloid leukaemia (AML) is a highly heterogeneous malignancy, with a poor 5-year overall survival rate of approximately 30%. Consequently, the search for novel therapeutic strategies is ongoing, and the identification of new vulnerabil
Externí odkaz:
https://doaj.org/article/9723f14e73bd4d35a8e5cf18373d820c
Publikováno v:
Infection and Drug Resistance, Vol Volume 17, Pp 4327-4332 (2024)
Sandip Patil, Xinye Li, Huirong Mai, Ying Wang, Xue Tang, Sixi Liu, Feiqiu Wen Department of Haematology and Oncology, Shenzhen Children’s Hospital, Shenzhen, Guangdong Province, People’s Republic of ChinaCorrespondence: Sixi Liu; Feiqiu Wen, Ema
Externí odkaz:
https://doaj.org/article/80c2a876960b4cc3845ed89ab3ec5dae
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract The aim of this study was to observe the effects of different conditioning regimens on fine immune indices after microtransplantation (MST) in patients with acute myeloid leukaemia (AML). This article discusses the possible immune mechanism
Externí odkaz:
https://doaj.org/article/890ea0f558e84faf8e8f3669324c8fd3
Autor:
D. A. Bogdanova, V. V. Shindyapin, E. D. Kolosova, T. V. Pukhalskaya, N. A. Budkina, A. A. Shatilova, O. N. Demidov
Publikováno v:
Медицинская иммунология, Vol 26, Iss 4, Pp 827-834 (2024)
Despite significant progress in basic and preclinical research into acute myeloid leukaemia (AML), the five-year survival rate for patients with AML remains poor, highlighting the urgent need for new combination therapies. Over the past decade, incre
Externí odkaz:
https://doaj.org/article/03ad46ee80924daaa334e6dc384a7762
Autor:
Kovtun, Iryna, von Bonin, Malte, Ibneeva, Liliia, Frimmel, Julia, Middeke, Jan Moritz, Kunadt, Desiree, Heberling, Lisa, Wobus, Manja, Bornhäuser, Martin, Grinenko, Tatyana
Acute myeloid leukemia (AML) is a malignancy with a poor prognosis. The expansion of leukemic cells is associated with the impairment of normal hematopoiesis, which can lead to severe morbidity in affected patients. Recent studies suggested that leuk
Externí odkaz:
https://tud.qucosa.de/id/qucosa%3A93443
https://tud.qucosa.de/api/qucosa%3A93443/attachment/ATT-0/
https://tud.qucosa.de/api/qucosa%3A93443/attachment/ATT-0/
Autor:
Weronika E. Borek, Luis Nobre, S. Federico Pedicona, Amy E. Campbell, Josie A. Christopher, Nazrath Nawaz, David N. Perkins, Pedro Moreno-Cardoso, Janet Kelsall, Harriet R. Ferguson, Bela Patel, Paolo Gallipoli, Andrea Arruda, Alex J. Ambinder, Andrew Thompson, Andrew Williamson, Gabriel Ghiaur, Mark D. Minden, John G. Gribben, David J. Britton, Pedro R. Cutillas, Arran D. Dokal
Publikováno v:
EBioMedicine, Vol 108, Iss , Pp 105316- (2024)
Summary: Background: Acute myeloid leukaemia (AML) is a bone marrow malignancy with poor prognosis. One of several treatments for AML is midostaurin combined with intensive chemotherapy (MIC), currently approved for FLT3 mutation-positive (FLT3-MP) A
Externí odkaz:
https://doaj.org/article/c1ed1c39383540cb899802e9a5af0c25
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-24 (2024)
Abstract Background and Objective Acute myeloid leukemia (AML) is an aggressive, heterogenous hematopoetic malignancies with poor long-term prognosis. T-cell mediated tumor killing plays a key role in tumor immunity. Here, we explored the prognostic
Externí odkaz:
https://doaj.org/article/377cf43ff4a5488db863a9e4cf2719ba
Autor:
Jinhua Ren, Jingjing Xu, Jiaqi Sun, Xueqiong Wu, Xiaozhu Yang, Chengjun Nie, Lingqiong Lan, Yanling Zeng, Xiaoyun Zheng, Jing Li, Qiaoxian Lin, Jianda Hu, Ting Yang
Publikováno v:
Frontiers in Microbiology, Vol 15 (2024)
Cytomegalovirus reactivation (CMVr) and bloodstream infections (BSI) are the most common infectious complications in patients after allogeneic haematopoietic stem cell transplantation (allo-HSCT). Both are associated with great high morbidity whilst
Externí odkaz:
https://doaj.org/article/765b1504628f406bad23be2e765fc9ea
Autor:
Han Wu, Manning Li, Chunyi Shou, Fangfang Shi, Xiaolu Song, Qingfeng Hu, Ying Wang, Yirui Chen, Xiangmin Tong
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 14 (2024)
BackgroundBloodstream infection (BSI) represent a prevalent complication in haematological malignancies (HMs). Typically, Patients with BSI usually undergo empirical treatment pending pathogen identification. The timely and effective management of BS
Externí odkaz:
https://doaj.org/article/0763ef055ec74c63aea70b5f86443860